Home / Pharmaceuticals / Oral Thin Film Drugs Market By Product (Sublingual Film, Fully Dissolving Buccal Film), By Indication (Migraine, Schizophrenia, Alzheimer’s Disease, Nausea & Vomiting, Opioid Dependence Tests) - Growth, Share, Opportunities & Competitive Analysis, 2017 - 2025

Oral Thin Film Drugs Market By Product (Sublingual Film, Fully Dissolving Buccal Film), By Indication (Migraine, Schizophrenia, Alzheimer’s Disease, Nausea & Vomiting, Opioid Dependence Tests) - Growth, Share, Opportunities & Competitive Analysis, 2017 - 2025

Published: Nov 2017 | Report Code: 58781-11-17

Thin film drugs have been identified as the alternative approach to the conventional dosage forms. Oral thin films are thin, flexible films of drug delivery that dissolve in the oral mucosa resulting in the rapid onset of action and improved bioavailability for drugs. The oral thin film are mostly used for the geriatric, pediatric and bedridden patient who are unable to intake the solid form of the drug. Rising demand for efficient drug delivery route and its acceptability in the region would further drive the thin film drug manufacturing market in the future.

The report titled “Global Oral Thin Film Drugs Market- Growth, Future Prospects and Competitive Analysis, 2017–2025” offers strategic insights into the overall oral thin film drugs market along with the market size and estimates for the duration 2017 to 2025. The research study covers in-depth analysis of market segments based on product type, and different geographical region.

In order to help strategic decision makers, the report also includes competitive profiling of the leading players in global oral thin film drugs market, attractive investment proposition and market positioning of key manufacturers sections. Geographically, the global oral thin film drugs market is studied for the following regional markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

Market size and forecast for these regional and country level markets are presented in this study for the period 2015-2025. Market growth rates for the forecast period 2015-2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global oral thin film drugs market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global oral thin film drugs market. This report concludes with company profiles section that highlights major information about the key players engaged in global oral thin film drugs market. In-depth competitive environment analysis and historical years (2015) market size data are also provided in the report. 

Thus, the research study provides a holistic view of the global oral thin film drugs market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.

Oral Thin Film Drugs Market

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Oral Thin Film Drugs Portraiture
2.2 Oral Thin Film Drugs Market, by Product Type, 2016 (US$ Mn)
2.3 Oral Thin Film Drugs Market, by Indication Type, 2016 (US$ Mn)
2.4 Oral Thin Film Drugs Market, by Geography, 2016 (Value %)

Chapter 3 Global Oral Thin Film Drugs Market Analysis
3.1 Global Oral Thin Film Drugs Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Mergers, Acquisition and Business Strategies
3.4 Attractive Investment Proposition
3.5 Competitive Analysis: Global Oral Thin Film Drugs Market, 2016 (Value %)

Chapter 4 Global Oral Thin Film Drugs Market Analysis, By Product Type
4.1 Overview
4.1.1 Market Share Analysis of Oral Thin Film Drugs Market, by Product Type, 2016
4.2 Sublingual Film
4.3 Fully Dissolving Buccal Film

Chapter 5 Global Oral Thin Film Drugs Market Analysis, By Indication Type
5.1 Overview
5.1.1 Market Attractive Proposition of Oral Thin Film Drugs Market, by Indication Type, 2016
5.2 Migraine
5.3 Schizophrenia
5.4 Alzheimer’s Disease
5.5 Nausea & Vomiting
5.6 Opioid Dependence Tests
5.7 Other Indication

Chapter 6 Global Oral Thin Film Drugs Market, By Geography
6.1 Preface
6.2 North America (U.S. & Canada)
6.2.1 North America Oral Thin Film Drugs Market, by Product Type, 2015-2025 (US$ Mn)
6.2.2 North America Oral Thin Film Drugs Market, by Indication Type, 2015-2025 (US$ Mn)
6.2.3 North America Oral Thin Film Drugs Market, by Country, 2015 – 2025 (US$ Mn)
6.3 Europe (U.K., Germany & Rest of Europe)
6.3.1 Europe Oral Thin Film Drugs Market, by Product Type, 2015-2025 (US$ Mn)
6.3.2 Europe Oral Thin Film Drugs Market, by Indication Type, 2015-2025 (US$ Mn)
6.3.3 Europe Oral Thin Film Drugs Market, by Country, 2015 – 2025 (US$ Mn)
6.4 Asia-Pacific (China, Japan & Rest of Asia-Pacific)
6.4.1 Asia Pacific Oral Thin Film Drugs Market, by Product Type, 2015-2025 (US$ Mn)
6.4.2 Asia Pacific Oral Thin Film Drugs Market, by Indication Type, 2015-2025 (US$ Mn)
6.4.3 Asia - Pacific Oral Thin Film Drugs Market, by Country, 2015 – 2025 (US$ Mn)
6.5 Latin America (Brazil, Mexico and Rest of LATAM)
6.5.1 Latin America Oral Thin Film Drugs Market, by Product Type, 2015-2025 (US$ Mn)
6.5.2 Latin America Oral Thin Film Drugs Market, by Indication Type, 2015-2025 (US$ Mn)
6.5.3 Latin America Oral Thin Film Drugs Market, by Country, 2015 – 2025 (US$ Mn)
6.6 Middle East and Africa (GCC and Rest of MEA)
6.6.1 Middle East and Africa Oral Thin Film Drugs Market, by Product Type, 2015-2025 (US$ Mn)
6.6.2 Middle East and Africa Oral Thin Film Drugs Market, by Indication Type, 2015-2025 (US$ Mn)
6.6.3 Middle East and Africa Oral Thin Film Drugs Market, by Country, 2015 – 2025 (US$ Mn)

Chapter 7 Company Profiles
7.1 MONOSOL RX
7.2 TESA LABTEC GMBH
7.3 PFIZER, INC
7.4 NOVARTIS AG
7.5 WOLTERS KLUWER
7.6 SOLVAY
7.7 ALLERGAN PLC
7.8 SUMITOMO DAINIPPON PHARMA CO. LTD
7.9 INTELGENX CORP
7.10 TRANSITION THERAPEUTICS, INC.

List of Tables :

TABLE 1 Global Oral Thin Film Drugs Market, By Product Type (US$ Mn), 2015– 2025 (Value)
TABLE 1 Global Oral Thin Film Drugs Market, By Indication Type (US$ Mn), 2015– 2025 (Value)
TABLE 2 Global Oral Thin Film Drugs Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 3 North America Oral Thin Film Drugs Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 4 North America Biological Safety Tests Market, by Indication Type, 2015 – 2025 (US$ Mn)
TABLE 5 North America Oral Thin Film Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 6 Europe Oral Thin Film Drugs Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 7 Europe Oral Thin Film Drugs Market, by Indication Type, 2015 – 2025 (US$ Mn)
TABLE 8 Europe Oral Thin Film Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 9 Asia Pacific Oral Thin Film Drugs Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 10 Asia Pacific Oral Thin Film Drugs Market, by Indication Type, 2015 – 2025 (US$ Mn)
TABLE 11 Asia - Pacific Oral Thin Film Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 12 Latin America Oral Thin Film Drugs Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 13 Latin America Oral Thin Film Drugs Market, by Indication Type, 2015 – 2025 (US$ Mn)
TABLE 14 Latin America Oral Thin Film Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 15 Middle East and Africa Oral Thin Film Drugs Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 16 Middle East and Africa Oral Thin Film Drugs Market, by Indication Type, 2015 – 2025 (US$ Mn)
TABLE 17 Middle East and Africa Oral Thin Film Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 18 MONOSOL RX: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 19 TESA LABTEC GMBH: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 20 PFIZER, INC: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 21 NOVARTIS AG: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 22 WOLTERS KLUWER: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 23 SOLVAY: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 24 ALLERGAN PLC: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 25 SUMITOMO DAINIPPON PHARMA CO. LTD: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 26 INTELGENX CORP: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 27 TRANSITION THERAPEUTICS, INC.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)

List of Figures :

FIG. 1 Oral Thin Film Drugs Market: Research Methodology
FIG. 2 Oral Thin Film Drugs Market, by Product Type, 2016 (US$ Mn)
FIG. 3 Oral Thin Film Drugs Market, by Indication Type, 2016 (US$ Mn)
FIG. 4 Oral Thin Film Drugs Market, by Geography, 2016 (Value %)
FIG. 5 Attractive Investment Proposition
FIG. 6 Competitive Analysis: Global Oral Thin Film Drugs Market, 2016 (Value %)
FIG. 7 Global Sublingual Film Market(US$ Mn), 2015-2025
FIG. 8 Global Fully Dissolving Buccal Film Market(US$ Mn), 2015-2025
FIG. 9 Global Oral Thin Films Drugs for Migraine Market(US$ Mn), 2015-2025
FIG. 10 Global Oral Thin Films Drugs for Schizophrenia Market(US$ Mn), 2015-2025
FIG. 11 Global Oral Thin Films Drugs for Alzheimer’s Disease Market (US$ Mn), 2015-2025
FIG. 12 Global Oral Thin Films Drugs for Nausea & Vomiting Market (US$ Mn), 2015-2025
FIG. 13 Global Oral Thin Films Drugs for Opioid Dependence Market (US$ Mn), 2015-2025
FIG. 14 Global Oral Thin Films Drugs for Other Indication Market(US$ Mn), 2015-2025

Based on the type of product, the oral thin film drugs market is segmented into:

  • Oral Thin Film
    • Sublingual Film
    • Fully Dissolving Buccal Film

Scientists throughout the pharmaceutical industry have been trying to explore thin films as the novel drug delivery tool. Thin film drugs have been identified as the alternative approach to the conventional dosage forms. Based on the type of products, the oral thin film drugs market is segmented into sublingual film and fully dissolving buccal film. The sublingual film held the largest share in the oral thin film drugs market due to the ease of consumption and its effectiveness as it provides rapid dissolution of the drug without the intake of water and rapid onset of action when delivered orally. There has been a good acceptance of oral drugs as it rules out the problem of dysphagia, a common problem due to difficulty in swallowing in the people of all ages and hence it is anticipated to exhibit tremendous growth rate during the forecast period of 2017 to 2025.

Oral Thin Film Drugs Market

Based on the type of indication, the oral thin film drugs market is segmented into:

  • Migraine
  • Schizophrenia
  • Alzheimer’s Disease
  • Nausea & Vomiting
  • Opioid Dependence
  • Others

The pharmaceutical industry is focusing its interest in shortening drug development timelines and efficient drug delivery platforms. Moreover, there is an increasing demand for efficient drug delivery technique as well as convenience in the transportation of the drug which has fuelled the oral thin film drugs market in the recent past. In terms of indication, the oral thin film drugs market is segmented as migraine, schizophrenia, Alzheimer’s disease, eye diseases, nausea & vomiting, opioid dependence and others. Thin film oral drugs make is it easy to swallow drugs without water, especially for pediatric, geriatric and neurodegenerative patients, where conventional drug delivery is difficult. Hence, Alzheimer’s disease, migraine and opioid dependence would lead the market in the future.

Oral Thin Film Drugs Market

For the purpose of this study, the global oral thin film drugs market is categorized as follows:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Oral Thin Film Drugs Market

For the purpose of this study, the global oral thin film drugs market is segmented into regional markets viz., North America, Europe, Asia Pacific, Latin America, Middle East and Africa. In the base year 2016, North America was observed as the largest regional segment in the oral thin film drugs market. U.S. led the North America oral thin film drugs market, accounting for more than 80% of the market share due to advanced technologies used in the pharmaceutical research and development for the discovery of novel drug delivery technique. Moreover, rising demand for efficient drug delivery route and its acceptability in the region would further drive the oral thin film drugs market in the future. However, favorable regulation, growing awareness among the masses and launch of novel products would make Asia Pacific the fastest growing geographical region during the forecast period. Moreover, rising target population in the region, and major contribution of India and China in the pharmaceutical development would further benefit the thin oral thin film drugs market in the region.

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Our Clients